330 related articles for article (PubMed ID: 30813110)
1. Impact of a mass media campaign on participation rates in a National Bowel Cancer Screening Program: a field experiment.
Durkin SJ; Broun K; Spittal MJ; Wakefield MA
BMJ Open; 2019 Jan; 9(1):e024267. PubMed ID: 30813110
[TBL] [Abstract][Full Text] [Related]
2. Engaging lower screening groups: a field experiment to evaluate the impact of a multiwave national campaign on participation in the National Bowel Cancer Screening Program.
Gascoyne C; Broun K; Morley B; Wyatt K; Feletto E; Durkin SJ
BMJ Open; 2023 Mar; 13(3):e065124. PubMed ID: 36921953
[TBL] [Abstract][Full Text] [Related]
3. Impact of a mass media campaign on participation in the Australian bowel cancer screening program.
Durkin S; Broun K; Guerin N; Morley B; Wakefield M
J Med Screen; 2020 Mar; 27(1):18-24. PubMed ID: 31530160
[TBL] [Abstract][Full Text] [Related]
4. Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia.
Worthington J; Feletto E; Lew JB; Broun K; Durkin S; Wakefield M; Grogan P; Harper T; Canfell K
Public Health; 2020 Feb; 179():90-99. PubMed ID: 31760206
[TBL] [Abstract][Full Text] [Related]
5. Increasing bowel cancer screening participation: integrating population-wide, primary care and more targeted approaches.
Lofti-Jam KL; O'Reilly CL; Feng CS; Wakefield MA; Durkin S; Broun KH
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384890
[TBL] [Abstract][Full Text] [Related]
6. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
[TBL] [Abstract][Full Text] [Related]
7. Does Digital Video Advertising Increase Population-Level Reach of Multimedia Campaigns? Evidence From the 2013 Tips From Former Smokers Campaign.
Davis KC; Shafer PR; Rodes R; Kim A; Hansen H; Patel D; Coln C; Beistle D
J Med Internet Res; 2016 Sep; 18(9):e235. PubMed ID: 27627853
[TBL] [Abstract][Full Text] [Related]
8. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
[TBL] [Abstract][Full Text] [Related]
9. Change in public awareness of colorectal cancer symptoms following the Be Cancer Alert Campaign in the multi-ethnic population of Malaysia.
Schliemann D; Paramasivam D; Dahlui M; Cardwell CR; Somasundaram S; Ibrahim Tamin NSB; Donnelly C; Su TT; Donnelly M
BMC Cancer; 2020 Mar; 20(1):252. PubMed ID: 32213173
[TBL] [Abstract][Full Text] [Related]
10. SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
McIntosh JG; Emery JD; Wood A; Chondros P; Goodwin BC; Trevena J; Wilson C; Chang S; Hocking J; Campbell T; Macrae F; Milley K; Lew JB; Nightingale C; Dixon I; Castelli M; Lee N; Innes L; Jolley T; Fletcher S; Buchanan L; Doncovio S; Broun K; Austin G; Jiang J; Jenkins MA
Trials; 2023 Nov; 24(1):723. PubMed ID: 37957680
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort.
He E; Lew JB; Egger S; Banks E; Ward RL; Beral V; Canfell K
Prev Med; 2018 Jan; 106():185-193. PubMed ID: 29109015
[TBL] [Abstract][Full Text] [Related]
12. The National Bowel Cancer Screening Program: time to achieve its potential to save lives.
Ee H; St John J
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384889
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
Lew JB; St John DJB; Macrae FA; Emery JD; Ee HC; Jenkins MA; He E; Grogan P; Caruana M; Sarfati D; Greuter MJE; Coupé VMH; Canfell K
Int J Cancer; 2018 Jul; 143(2):269-282. PubMed ID: 29441568
[TBL] [Abstract][Full Text] [Related]
14. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.
Dillon M; Flander L; Buchanan DD; Macrae FA; Emery JD; Winship IM; Boussioutas A; Giles GG; Hopper JL; Jenkins MA; Ait Ouakrim D
PLoS Med; 2018 Aug; 15(8):e1002630. PubMed ID: 30114221
[TBL] [Abstract][Full Text] [Related]
15. History, development and future of cancer screening in Australia.
Olver IN; Roder D
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858
[TBL] [Abstract][Full Text] [Related]
16. Improving colonoscopy prioritisation and promoting the National Bowel Cancer Screening Program: keys to reducing bowel cancer burden.
Grogan P; He E; Pockney P
Public Health Res Pract; 2023 Mar; 33(1):. PubMed ID: 36918394
[TBL] [Abstract][Full Text] [Related]
17. Outcomes from a mass media campaign to promote cervical screening in NSW, Australia.
Morrell S; Perez DA; Hardy M; Cotter T; Bishop JF
J Epidemiol Community Health; 2010 Sep; 64(9):777-83. PubMed ID: 19822553
[TBL] [Abstract][Full Text] [Related]
18. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG
Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080
[TBL] [Abstract][Full Text] [Related]
19. Can anti-smoking television advertising affect smoking behaviour? controlled trial of the Health Education Authority for England's anti-smoking TV campaign.
McVey D; Stapleton J
Tob Control; 2000 Sep; 9(3):273-82. PubMed ID: 10982571
[TBL] [Abstract][Full Text] [Related]
20. What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?
Flander L; Dekker E; Andersen B; Larsen MB; Steele RJ; Malila N; Sarkeala T; van der Vlugt M; de Klerk C; Knottnerus B; Bertels L; Woudstra A; Spaander MCW; Fransen M; Heinavaara S; Dillon M; Ait Ouakrim D; Jenkins M
Cancer Control; 2022; 29():10732748221121383. PubMed ID: 35969473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
